GHRH analog and ghrelin mimetic. Pulsatile GH release research.
$90/vial
DOSE
5+5 MG
UNIT VALUE
0.111 mg per dollar
PURITY (HPLC)
99.4%
BATCH
NLL-CJI-2604
MOLECULAR WEIGHT
CJC-1295: 3,367.91 Da, Ipamorelin: 711.86 Da
SHIPPING
US, USPS Priority
For in vitro research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. US shipping only.
RESEARCH OVERVIEW
CJC-1295 is a growth hormone releasing hormone (GHRH) analog. Ipamorelin is a selective ghrelin receptor agonist. Stacked, they are studied for synergistic effects on pulsatile growth hormone release in vitro and in animal models.
RECONSTITUTION + STORAGE
RECONSTITUTION
2 mL bacteriostatic water yields 2.5 mg/mL of each peptide. Research use only.
STORAGE
Lyophilized at room temp. Reconstituted, 2 to 8 degrees Celsius for up to 28 days.
RESEARCH CITATIONS
Citations are listed for research context only and do not imply efficacy claims for human use.
FAQ
A combined research stack of a GHRH analog (CJC-1295) and a ghrelin receptor agonist (Ipamorelin). Studied for pulsatile GH release in vitro.
Research suggests synergistic activity, GHRH driving the release while ghrelin agonism amplifies the pulse.
RECONSTITUTION + DOSING REFERENCE
Enter the BAC water volume and target research dose. The calculator returns concentration, units to draw on a reference syringe, doses per vial, and vial duration. For laboratory research reference only.